|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 157.14 USD | -2.87% |
|
-6.66% | -13.96% |
| 10-14 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| 10-08 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
Stock exchange
Nasdaq
AXSM 157.14 $
-2.87%
137M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| AXSM | 157.14USD | -2.87% | 137M $ | ||
CBOE
| AXSM | 157.13USD | -2.92% | 3.38M $ | |
|
Tradegate
| 19X | 139.80EUR | -3.12% | 38.72K € | |
|
London S.E.
| 0HKF | 163.84USD | -12.41% | 16.38K $ | |
|
Boerse Muenchen
| 19X | 140.10EUR | -2.81% | 840.6 € | |
|
Börse Stuttgart
| 19X | 139.15EUR | -3.54% | 695.75 € | |
|
Deutsche Boerse AG
| 19X | 142.60EUR | -2.19% | 0 € | |
|
Borsa Italiana
| 1AXSM | 158.60EUR | -2.43% | 0 € | |
|
Xetra
| 19X | 140.75EUR | -5.66% | 0 € |
Quotes 5-day view: Axsome Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-10-12 | 2026-10-13 | 2026-10-14 | 2026-10-15 | 2026-10-16 | |
|---|---|---|---|---|---|
| Last | US$166.00 | US$156.32 | US$162.22 | US$161.79 | US$157.14 |
| Volume | 663,002 | 1,328,730 | 893,237 | 802,617 | 873,150 |
| Change | -1.40% | -5.83% | +3.77% | -0.27% | -2.87% |
| Opening | US$169.50 | US$166.01 | US$156.44 | US$163.44 | US$160.43 |
| High | US$170.80 | US$166.55 | US$164.00 | US$169.96 | US$160.43 |
| Low | US$165.02 | US$155.69 | US$155.18 | US$160.27 | US$156.09 |
Performance
| 1 day | -2.87% | ||
| 1 week | -6.66% | ||
| Current month | -14.78% | ||
| 1 month | -25.87% | ||
| 3 months | -33.71% | ||
| 6 months | -14.69% | ||
| Current year | -13.96% | ||
| 1 year | +25.71% | ||
| 3 years | +134.85% | ||
| 5 years | +291.87% | ||
| 10 years | +2,055.56% |
Volumes
marketsDaily volume
873,152
Estimated daily volume
873,152
Avg. Volume 20 sessions
971,253
Daily volume ratio
0.9
Avg. Volume 20 sessions USD
152,622,696.42
Record volume 1
51,674,500
Record volume 2
25,307,160
Record volume 3
23,596,000
Capital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
8,474,692,544
Net sales (USD)
638,496,000
Number of employees
1,346
Sales / Employee (USD)
474,366
Free-Float
84.69%
Free-Float capitalization (USD)
7,177,391,240
Average Daily Capital Traded
1.8%
Indicators
Moving average 5 days
160.69
Moving average 20 days
181.79
Moving average 50 days
199
Moving average 100 days
217.38
Price spread / (MMA5)
+2.26%
Price spread / (MMA20)
+15.69%
Price spread / (MMA50)
+26.64%
Price spread / (MMA100)
+38.34%
STIM
RSI 9 days
24.45
RSI 14 days
26.33
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.87% | -6.66% | +25.71% | +134.85% | 8.47B | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,116B | |
| +0.90% | -2.25% | +33.02% | +62.23% | 610B | |
| +0.71% | +3.24% | +25.81% | +93.86% | 501B | |
| +0.52% | +0.24% | +73.92% | +40.15% | 358B | |
| -0.13% | +5.98% | +32.91% | +50.39% | 366B | |
| -0.95% | +4.70% | +19.51% | +43.00% | 288B | |
| -1.98% | +3.73% | -0.86% | +13.43% | 261B | |
| -0.35% | +4.25% | +46.21% | +50.76% | 235B | |
| -0.75% | +3.32% | +32.53% | +97.21% | 195B | |
| Average | -0.45% | +2.98% | +34.22% | +68.97% | 393.82B | |
| Weighted average by Cap. | +0.12% | +4.13% | +39.10% | +71.50% |
Historical Quotes: Axsome Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
6ca59c0.5sbMPIEcG040IEWhAtkqzFmxxL8GcrI6k7UQgKIp3NI.hYWlY8clIj18chfYO55JhiDihdxQBcti3dxh8ZV4g-qltfhf-3peKV1WIg
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 157.14 | 327,032 | 608,554 |
| 16:00:00 | 157.08 | 718 | 281,522 |
| 16:00:00 | 157.08 | 100 | 280,804 |
| 15:59:59 | 157.08 | 100 | 280,704 |
| 15:59:59 | 157.08 | 146 | 280,604 |
| 15:59:59 | 157.06 | 300 | 280,458 |
| 15:59:59 | 157.06 | 300 | 280,158 |
| 15:59:59 | 157.06 | 1,403 | 279,858 |
| 15:59:59 | 157.06 | 200 | 278,455 |
| 15:59:59 | 157.06 | 156 | 278,255 |
Price Extremes
| 1 week | 155.18 |  | 170.8 |
| 1 month | 155.18 | | 213.26 |
| Current year | 152.28 | | 260.19 |
| 1 year | 123.5 | | 260.19 |
| 3 years | 55.02 | | 260.19 |
| 5 years | 20.63 | | 260.19 |
| 10 years | 1.94 | | 260.19 |
Monthly variations
Annual variations
| 2026 | -13.96% | ||
| 2025 | +115.86% | ||
| 2024 | +6.31% | ||
| 2023 | +3.19% | ||
| 2022 | +104.16% | ||
| 2021 | -53.63% | ||
| 2020 | -21.18% | ||
| 2019 | +3,565.25% | ||
| 2018 | -49.64% | ||
| 2017 | -17.04% | ||
| 2016 | -27.18% | ||
| 2015 | +6.06% |
- Stock Market
- Stocks
- AXSM Stock
- Quotes Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
